CME Group Inc. Class A (CME)

NASDAQ:
CME
| Latest update: Nov 4, 2025, 1:44 PM

Stock events for CME Group, Inc. (CME)

In the past six months, CME Group's stock has been influenced by several events. In the third quarter of 2025, the company reported diluted EPS of $2.49, or an adjusted EPS of $2.68, slightly beating estimates, while revenue was $1.54 billion, a 3.0% decrease year-over-year. Deutsche Bank upgraded CME Group to "Buy," raising its price target to $300.00, while Morgan Stanley raised its price target to $314.00, maintaining an "overweight" rating. TD Cowen increased its price target to $290.00, maintaining a "hold" rating. Goldman Sachs increased its price target slightly to $263.00 but maintained a "sell" rating, and UBS Group dropped its price target to $285.00, maintaining a "neutral" rating. In May 2025, CME Group reported a record average daily volume of 28.9 million contracts, an 11% increase from the previous year. Insider ownership concentration decreased by 5.77%, with Chairman and CEO Terrence A Duffy leading insider buying activity and Chief Information Officer Sunil Cutinho recording the highest insider sale volume. CME Group issued a disciplinary action against J.P. Morgan Securities LLC for a regulatory violation, resulting in a $50,000 fine.

Demand Seasonality affecting CME Group, Inc.’s stock price

Demand seasonality for CME Group's products and services is influenced by market volatility and uncertainty, which tend to increase trading volume and revenues. Historically, CME Group shares perform stronger in the first and fourth quarters. Specific agricultural products exhibit seasonal demand, such as the impact of "grilling season" on beef and pork demand. CME Group has seen record trading volumes in cryptocurrency futures and options, indicating growing demand in this asset class.

Overview of CME Group, Inc.’s business

CME Group Inc. is a leading American financial services company based in Chicago, operating the world's largest and most diverse derivatives marketplace. It manages exchanges like CME, CBOT, NYMEX, and COMEX, providing platforms for trading futures and options across various asset classes, including interest rates, equity indexes, FX, energy, agricultural commodities, metals, and cryptocurrencies. The company offers fixed income and foreign currency trading services through BrokerTec and EBS, respectively, and clearing house services via CME Clearing. CME Group also holds a 27% stake in S&P Dow Jones Indices.

CME’s Geographic footprint

CME Group operates globally, serving institutions and individuals in approximately 150 countries. Headquartered in Chicago, it has offices in key financial centers like New York, Houston, and Washington. Its global distribution network and CME Globex platform enable worldwide market access, targeting markets in Latin America, Europe, the Middle East, Africa, and the Asia-Pacific region.

CME Corporate Image Assessment

CME Group maintains a strong brand reputation as the world's leading derivatives marketplace, known for its robust and transparent trading environments. A disciplinary action against J.P. Morgan Securities LLC for a regulatory violation had a muted impact on CME's stock price. CME Group acknowledges the importance of maintaining its brand and reputation as a risk factor in its financial filings.

Ownership

CME Group Inc. is predominantly owned by institutional investors, who hold approximately 88.55% of the company's stock, while individual insiders own about 1.94%. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., State Street Corp, Capital Research and Management Company, and JPMorgan Chase & Co. Significant individual insider holders include William R Shepard, Terrence A Duffy, William W Hobert, Howard J Siegel, and Kevin Kometer.

Expert AI

Show me the sentiment for CME Group, Inc.
What's the latest sentiment for CME Group, Inc.?

Price Chart

$264.16

0.19%
(1 month)

Top Shareholders

BlackRock, Inc.
8.33%
State Street Corp.
4.56%
The Capital Group Cos., Inc.
4.01%
JPMorgan Chase & Co.
3.41%
Morgan Stanley
2.62%
Geode Holdings Trust
2.55%
T. Rowe Price Group, Inc.
1.74%
UBS Group AG
1.68%
The Bank of New York Mellon Corp.
1.49%
Ameriprise Financial, Inc.
1.30%
Raymond James Financial, Inc.
1.14%
FMR LLC
1.12%
Arrowstreet Capital Holding LLC
1.06%
Northern Trust Corp.
1.05%
Franklin Resources, Inc.
1.01%
GQG Partners, Inc.
0.99%
Royal Bank of Canada
0.95%
FIL Ltd.
0.88%
The Goldman Sachs Group, Inc.
0.79%
Fiera Capital Corp.
0.77%

Trade Ideas for CME

Today

Sentiment for CME

News
Social

Buzz Talk for CME

Today

Social Media

FAQ

What is the current stock price of CME Group, Inc.?

As of the latest update, CME Group, Inc.'s stock is trading at $264.16 per share.

What’s happening with CME Group, Inc. stock today?

Today, CME Group, Inc. stock is down by -0.19%, possibly due to news.

What is the market sentiment around CME Group, Inc. stock?

Current sentiment around CME Group, Inc. stock is positive, based on recent news, trading volume, and analyst opinions.

Is CME Group, Inc.'s stock price growing?

Over the past month, CME Group, Inc.'s stock price has decreased by -0.19%.

How can I buy CME Group, Inc. stock?

You can buy CME Group, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol CME

Who are the major shareholders of CME Group, Inc. stock?

Major shareholders of CME Group, Inc. include institutions such as BlackRock, Inc. (8.33%), State Street Corp. (4.56%), The Capital Group Cos., Inc. (4.01%) ... , according to the latest filings.